Oramed Pharmaceuticals Inc (ORMP) stock news · $87.2M cap
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
This ORMP news page leads with what Oramed Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for ORMP yet. We will not pad this page with generic market recap.
Latest reported ORMP revenue for 2025-09-30 was $2.0M. Net income was $48.4M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ORMP currently screens at market cap $87.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ORMP stock page; for the tape open the quote page.
ORMP stock news FAQ
What are ORMP's latest revenue and net income?
Latest cached Oramed Pharmaceuticals Inc (ORMP) revenue for Sep 30, 2025 was $2.0M. Net income was $48.4M. Statements: https://lician.com/financials/ormp
How did ORMP revenue change from the prior cached period?
Cached Oramed Pharmaceuticals Inc (ORMP) revenue was unchanged from $2.0M (Jun 30, 2025) to $2.0M (Sep 30, 2025). Statements: https://lician.com/financials/ormp
What is ORMP's market cap?
Oramed Pharmaceuticals Inc (ORMP) market cap is $87.2M on the latest cached fundamentals snapshot.
What kind of company is ORMP?
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Where is ORMP stock news listed?
Cached stock news for Oramed Pharmaceuticals Inc (ORMP) is listed at https://lician.com/news/ormp. Filings: https://lician.com/sec/ormp
Not investment advice.